Related Experiment Videos
Coronary heart disease is a multifactorial disease
1Department of Clinical Pharmacology, Imperial College School of Medicine, Paddington, London, United Kingdom.
Insights
Coronary heart disease (CHD) is a leading cause of death. Identifying key risk factors like dyslipidemia, blood pressure, and smoking is crucial for effective prevention and treatment strategies.
Area of Science:
- Cardiovascular Science
- Epidemiology
- Preventive Medicine
Background:
- Coronary heart disease (CHD) is a major global health concern.
- Numerous variables are linked to CHD, but key factors include blood pressure, lipids, smoking, and diabetes.
- Dyslipidemia is a critical CHD risk factor, significantly influencing the impact of other risk factors.
Purpose of the Study:
- To identify major risk factors for coronary heart disease (CHD).
- To emphasize the pivotal role of dyslipidemia in CHD development.
- To highlight the clustering and multiplicative interaction of CHD risk factors.
Main Methods:
- Review of laboratory, experimental, and epidemiologic data.
- Analysis of observational data on CHD risk factor prevalence and interaction.
- Examination of clinical trial evidence and treatment guidelines.
Main Results:
- Dyslipidemia is a pivotal CHD risk factor, diminishing the impact of other factors when absent.
- CHD risk factors cluster and interact multiplicatively, meaning combined factors pose a greater risk than additive.
- Low CHD incidence in populations with low low-density lipoprotein cholesterol despite high smoking/hypertension rates.
Conclusions:
- CHD is a multifactorial disease influenced by interacting risk factors.
- A holistic approach considering multiple risk factors is essential for accurate CHD risk evaluation and prevention.
- Current trends in CHD management emphasize integrated risk assessment over isolated factor targets.
Abstract:
Coronary heart disease (CHD) is the leading cause of death in the Western World. For effective treatment and prevention strategies to be put in place, the major risk factors associated with this disease must be identified. Data show that almost 300 variables are statistically associated with CHD. However, evidence suggests that the vast majority of coronary events can be explained on the basis of blood pressure, lipids, smoking, and diabetes. Laboratory, experimental, and epidemiologic data identify dyslipidemia as a pivotal CHD risk factor, in the absence of which other risk factors cease to produce any important increase in absolute risk of events. For example, in populations with relatively low levels of low-density lipoprotein cholesterol, such as China and Japan, the incidence of CHD remains low even when smoking and hypertension are highly prevalent. Observational data have clearly established that CHD risk factors tend to cluster in individuals. The impact of coexisting risk factors is greater than additive, and indeed is usually multiplicative. The implications of such an interactive effect are that relatively normal levels of two or more risk factors in coexistence may have a profound impact on risk. Despite these findings, in the past most treatment algorithms have viewed risk factors separately and have recommended discrete treatment targets. More recent guidelines have taken a broader view and provide simple, yet accurate, methods of evaluating absolute risk based on the consideration of several risk factors. Coronary heart disease is clearly a multifactorial disease with risk factors that tend to cluster and interact in an individual to determine the level of coronary risk. The current trend towards a more holistic approach in CHD risk evaluation and preventive management appears logical based on evidence from animal-experimental, observational, and clinical trial evidence.